Methoxydimethyltryptamines: Clinical Trials

10 trials of Methoxydimethyltryptamines, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 recruiting, 1 terminated. 10 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 8, Recruiting 1, Terminated 1
Phase 22Completed 2

Follow Methoxydimethyltryptamines: new trials by email Literature Review of Methoxydimethyltryptamines trials Research Report on Methoxydimethyltryptamines

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
0.2 mg/min 5-MeO-DMT, 0.4 mg/min 5-MeO-DMT, 0.6 mg/min 5-MeO-DMT - 5-methoxy-dimethyltryptamine (5-MeO-DMT)
Phase 1RecruitingUniversity Hospital, Basel, Switzerland402026-08-132026-10-09
Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects
5 Methoxy N,N Dimethyltryptamine, GH001 Aerosol Delivery System - Healthy Adult
Phase 1CompletedGH Research Ireland Limited132026-03-182026-10-07
Safety, Tolerability, and Efficacy of Sublingual Microdoses of 5-MeO-DMT for Depression and Anxiety
BMND08, Brain electrical activity monitor, Pharmacokinetic Study of Sublingually Administered Psychoactive Substance - Healthy Volunteers
Phase 1 / Phase 2CompletedBiomind Labs Inc.402024-10-212025-03-05
Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects
5 Methoxy N,N Dimethyltryptamine - Healthy Volunteers
Phase 1TerminatedGH Research Ireland Limited712024-08-012026-10-09
Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers
5-methoxy-N,N-dimethyltryptamine succinate salt, Placebo - Pharmacokinetics, Safety
Phase 1CompletedUsona Institute542022-12-272023-11-30
Safety and Pharmacokinetics of GH002 in Healthy Volunteers
5 Methoxy N,N Dimethyltryptamine, Placebo - Healthy Volunteers
Phase 1CompletedGH Research Ireland Limited642022-12-222024-01-25
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
5-MeO-DMT, Placebo - Pharmacokinetics in Healthy Adults
Phase 1CompletedBeckley Psytech Limited362021-09-222022-10-12
Pharmacokinetics of GH001 in Healthy Volunteers
5 Methoxy N,N Dimethyltryptamine, Placebo - Healthy Volunteers
Phase 1CompletedGH Research Ireland Limited462021-06-212021-12-20
Clinical Study of GH001 in Depression
5 Methoxy N,N Dimethyltryptamine - Treatment Resistant Depression, Major Depressive Disorder
Phase 1 / Phase 2CompletedGH Research Ireland Limited162019-11-122023-08-15
Safety of GH001 in Healthy Volunteers
5 Methoxy N,N Dimethyltryptamine - Healthy Volunteers
Phase 1CompletedGH Research Ireland Limited222019-03-132023-08-15

Conditions studied

Depression (2)  ·  Anxiety Disorders (1)  ·  Depressive Disorder, Major (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Mood Disorders (1)

Sponsors

GH Research Ireland Limited (6)  ·  Beckley Psytech Limited (1)  ·  Biomind Labs Inc. (1)  ·  University Hospital, Basel, Switzerland (1)  ·  Usona Institute (1)

Countries

Netherlands (4)  ·  United Kingdom (2)  ·  United States (2)  ·  Argentina (1)  ·  Switzerland (1)

Top investigators

Martin A. Bruno, PhD (1)  ·  Severin Vogt, Dr. med. (1)

Results publications

PMID 34912222, PMID 37409159, PMID 40659913

NIH funding

2018 (2), 2025 (1)